跳至主要内容
临床试验/NCT00802620
NCT00802620Unknown1 期

Amniotic Membrane Associated With Conjunctival Autograft Versus Conjunctival Autograft for Recurrent Pterygia

Federal University of São Paulo0 个研究点目标入组 40 人开始时间: 2005年6月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
40
主要终点
Amniotic membrane treatment for recurrent pterygia

研究概览

简要总结

The purpose of this study is to compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia.

详细描述

Patients with recurrent pterygia without symblepharon were randomly assigned to undertake pterygium excision followed by amniotic membrane associated with a small conjunctival autograft (2x3mm) or conjunctival autograft (approximately 5x8mm) alone. The patients were examined after 1, 7, 30, 90, 180 and 360 days after the surgery. Recurrence was considered as a fibrovascular ingrowth of 1.5 mm or more beyond the limbus with conjunctival drag.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recurrent pterygium

排除标准

  • Less than 15 year of age
  • Symblepharon
  • Glaucoma,
  • Ocular Allergy
  • Ocular surface disorders

结局指标

主要结局

Amniotic membrane treatment for recurrent pterygia

时间窗: one year

次要结局

未报告次要终点

研究者

发起方
Federal University of São Paulo
申办方类型
Other

相似试验